跳至主要内容
临床试验/IRCT20210219050412N1
IRCT20210219050412N1招募中3 期

The effect of ellagic acid supplementation on glycemic status, lipid profile, oxidative stress indices and anthropometric parameters in the military with type 2 diabetes

Bagheiat-allah University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Willingness to cooperate
  • Diabetes type 2
  • Age 60-30 years
  • Patients whose blood sugar is well controlled by taking oral hypoglycemic drugs.
  • Body Mass Index (BMI): 23-35 kg / m2

排除标准

  • Reluctance to cooperate
  • Taking multivitamin and mineral supplements during the last 3 months
  • Follow a specific diet and physical activity for the past 3 months
  • Taking corticosteroids and nonsteroidal anti-inflammatory drugs
  • Insulin users
  • Chronic diseases such as cardiovascular, renal, hepatic and hypothyroidism and hyperthyroidism.
  • Having specific physiological conditions such as pregnancy and lactation

研究者

发起方
Bagheiat-allah University of Medical Sciences

相似试验